Credits: None available.
Social Media Moderator – Chris Malaisrie
Late Breaking Science III: Controversies in Contemporary Management of AS - Case Presentation: What Would You Do? - AHA Discussant
Global Comparison of a Rivaroxaban-Based Antithrombotic Strategy versus an Antiplatelet-Based Strategy After Transcathether Aortic Valve Replacement to Optimize Clinical Outcomes (GALILEO) Trial: Primary Results – George Dangas
Discussant – Elaine Hylek
Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy with an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves (GALILEO-4D) – Ole De Backer
Discussant – Victoria Delgado
Balloon-Expandable versus Self-Expandable TAVR on Paravalvular Regurgitation and 2-Year Mortality: A Propensity-Matched Comparison From the FRANCE-TAVI Registry – Eric Van Belle
Discussant – Dharam Kumbhani
Early Surgery versus Conventional Management for Asymptomatic Severe Aortic Stenosis - Duk-Hyun Kang
Discussant – Robert Bonow
Late Breaking Science III: Controversies in Contemporary Management of AS - Case Revisited and Discussion
You must be logged in and own this session in order to post comments.